Omada Health, Inc. (OMDA) Reports Q2 Loss of $0.24, provides guidance

Omada Health, Inc. (NASDAQ: OMDA) reported Q2 EPS of ($0.24). Revenue for the quarter came in at $61 million, versus $0 reported last year.

GUIDANCE:

Omada Health, Inc. sees FY2025 revenue of $235-241 million, versus the consensus of $221.8 million. Adjusted EBITDA loss in the range of $9 million to $5 million

For earnings history and earnings-related data on Omada Health, Inc. (OMDA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c